Latest Ribavirin Stories

2011-01-05 14:20:40

Scientists at Inserm and Institut Pasteur have performed biomarker discovery on patients being treated for chronic hepatitis C infection.

2011-01-04 16:00:00

PRINCETON, N.J., Jan. 4, 2011 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the 29th Annual J.P. Morgan Healthcare Conference to be held January 10-13, 2011 at the Westin St. Francis Hotel, San Francisco, CA.

2011-01-04 15:05:00

SAN DIEGO, Jan. 4, 2011 /PRNewswire/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it has initiated the planned Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin.

2010-12-14 05:45:00

PRINCETON, N.J., Dec. 14, 2010 /PRNewswire/ -- Pharmasset, Inc. (Nasdaq: VRUS) announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV).

2010-12-13 05:45:00

PRINCETON, N.J., Dec. 13, 2010 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the Deutsche Bank BioFEST Conference to be held December 14 and 15, 2010 at the Four Seasons Hotel, Boston, MA.

2010-11-23 15:56:00

PRINCETON, N.J., Nov. 23, 2010 /PRNewswire-FirstCall/ -- Pharmasset, Inc.

2010-11-18 00:00:00

HUDDINGE, Sweden, November 18, 2010 /PRNewswire/ -- - Once Daily Novel Therapy in Treatment-Experienced Hepatitis C Patients Highlights of the Study TMC435 Added to Standard of Care: - Increased the response rates and antiviral efficacy, which progressed through to week 24 - Increased the number of patients with undetectable Hepatitis C Virus (HCV) levels through week 4, 12 and 24 - Safe and well tolerated Medivir AB (OMX: MVIR), the emerging...

2010-11-17 22:10:15

Scientists at Emory University and the University of St. Andrews have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever.

2010-11-16 12:19:00

In the news release, "The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments, issued Nov.

Latest Ribavirin Reference Libraries

2011-02-17 15:14:03

Lassa fever, first described in 1969 in Lassa, is an acute viral hemorrhagic fever. Clinical cases were known a decade before this but were not associated with this viral pathogen. It is endemic in West African countries and causes approximately 5,000 deaths. The Natal Multimammate Mouse is the primary animal host. The rodent is a source of protein but the virus is usually transmitted by the contact with the feces and urine of animals accessing grain stores in residences. The lassa virus...

More Articles (1 articles) »
Word of the Day
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.